GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Gufic Biosciences GUFICBIO.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

474.35

+10.22%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2025

Revenue

₹8.20bn

FY2016FY2025

Net income

₹696.5m

FY2016FY2025

Free cash flow

₹470.4m

FY2016FY2025

Shareholders' equity

₹6.01bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₹8.20bn₹8.07bn₹6.91bn₹7.79bn₹4.88bn₹3.58bn₹3.51bn₹3.09bn₹2.60bn₹2.02bn
Gross profit₹4.05bn₹3.79bn₹3.26bn₹3.38bn₹2.15bn₹1.59bn₹1.47bn₹1.44bn₹1.10bn₹1.00bn
Research and development—————₹20.0m₹20.8m₹52.9m₹33.2m—
Operating income₹1.17bn₹1.31bn₹1.15bn₹1.29bn₹676.3m₹362.3m₹413.4m₹359.8m₹192.7m₹159.0m
Net income₹696.5m₹861.4m₹797.0m₹958.4m₹442.3m₹228.6m₹219.4m₹164.8m₹90.2m₹73.2m
Diluted earnings per share6.958.617.999.904.562.362.812.131.160.94

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₹11.69bn₹10.93bn₹8.61bn₹5.21bn₹3.92bn₹3.56bn₹2.80bn₹2.38bn₹1.78bn₹1.52bn
Cash and short-term investments₹290.0m₹134.6m₹466.6m₹264.7m₹131.3m₹107.9m₹75.5m₹74.5m₹56.4m₹62.2m
Total liabilities₹5.68bn₹5.60bn₹5.13bn₹2.52bn₹2.19bn₹2.60bn₹2.04bn₹1.84bn₹1.41bn₹1.23bn
Debt₹3.04bn₹3.08bn₹3.19bn₹543.3m₹545.7m₹1.07bn₹960.0m₹774.9m₹535.9m₹397.4m
Shareholders' equity₹6.01bn₹5.33bn₹3.48bn₹2.69bn₹1.73bn₹958.5m₹753.5m₹541.4m₹373.3m₹287.7m
Shares outstanding100m100m100m97m97m97m78m77m78m78m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₹1.23bn−₹74.6m−₹265.9m₹1.06bn₹890.6m₹456.9m₹52.1m−₹48.2m−₹41.3m−₹43.2m
Capital spending−₹755.3m−₹1.13bn−₹1.88bn−₹874.5m−₹142.1m−₹401.2m−₹130.8m−₹82.4m−₹41.5m−₹9.7m
Free cash flow₹470.4m−₹1.20bn−₹2.14bn₹187.9m₹748.5m₹55.8m−₹78.8m−₹130.6m−₹82.8m−₹52.9m
Dividends paid−₹10.0m−₹9.7m−₹10.4m−₹9.2m−₹3.6m−₹4.9m−₹3.9m−₹3.9m−₹3.9m−₹3.9m

Latest quarters

By quarter end

Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024
Revenue₹2.31bn₹2.37bn₹2.24bn₹2.05bn₹2.08bn₹2.04bn₹2.03bn₹1.95bn
Gross profit₹1.30bn₹1.33bn₹1.23bn₹1.15bn₹1.14bn₹1.08bn₹1.08bn₹1.06bn
Operating income₹252.9m₹300.7m₹255.8m₹199.4m₹293.1m₹343.2m₹314.7m₹298.9m
Net income₹124.2m₹168.2m₹130.7m₹77.2m₹193.1m₹217.7m₹208.6m₹200.5m
Diluted earnings per share1.241.681.300.771.932.182.082.00
Cash from operations—₹591.0m—₹1.23bn—₹894.0m—−₹74.0m
Capital spending—−₹156.0m—−₹755.0m—−₹408.0m—−₹1.13bn
Free cash flow—₹435.0m—₹470.0m—₹486.0m—−₹1.20bn
Total assets—₹12.71bn—₹11.69bn—₹11.05bn—₹10.93bn
Cash and short-term investments—₹880.8m—₹290.2m—₹194.0m—₹134.8m
Debt—₹1.34bn—₹1.50bn—₹1.53bn—₹1.66bn
Shareholders' equity—₹6.31bn—₹6.01bn—₹5.74bn—₹5.33bn

Financial ratios

Data as of 22 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Gross margin36.0%36.2%50.5%50.9%45.7%47.4%
Operating margin16.6%16.7%35.9%36.5%16.6%14.0%
Net margin6.8%8.5%10.7%11.5%12.3%9.1%
Return on equity9.7%11.6%16.2%22.9%35.6%25.5%
Return on assets4.8%6.0%7.9%9.3%18.4%11.3%
Free cash flow yield1.0%4.0%2.4%3.6%4.5%2.4%
Revenue growth15.2%1.6%16.8%-11.4%59.8%28.7%
Earnings growth-7.8%-19.1%8.1%-16.8%116.7%95.0%
Current ratio1.55x1.61x1.61x1.61x1.72x1.59x
Debt to equity0.59x0.53x0.60x0.91x0.24x0.34x
Equity ratio49.5%51.4%48.7%40.4%51.6%44.2%
Interest coverage4.29x5.92x18.84x30.66x37.02x5.00x
R&D as a share of sales1.1%0.7%0.7%0.7%0.6%0.4%
Buybacks as a share of market value-0.2%-0.3%-0.2%-3.1%0.1%-0.3%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue1.7%18.0%18.4%
Operating income-3.0%26.5%27.2%
Net income-10.1%25.0%32.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin48.2%46.8%46.2%45.9%
Operating margin15.3%15.9%15.1%13.8%
Net margin9.6%10.7%10.1%8.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings48.452.939.622.851.849.521.644.5108.655.9
Price to sales4.15.74.62.84.73.21.42.43.82.0

Dividends and splits

Per share, in the currency the company pays

Paid for 18 years. Last went ex-dividend on 28 Aug 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.100.100.100.100.100.050.050.05

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.